HARVARD BIOSCIENCE INC
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
HBIO$9.09+8.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| HARVARD BIOSCIENCE, INC. | ||
|---|---|---|
| CONSOLIDATED STATEMENTS OF OPERATIONS | ||
| (Unaudited, in thousands, except per share data) | ||
| Three Months Ended March 31, | ||
| 2024 | 2023 | |
| Revenues | $24,512 | $29,975 |
| Cost of revenues | 9,740 | 11,629 |
| Gross profit | 14,772 | 18,346 |
| Sales and marketing expenses | 5,904 | 5,978 |
| General and administrative expenses | 5,963 | 6,334 |
| Research and development expenses | 2,885 | 2,897 |
| Amortization of intangible assets | 1,333 | 1,388 |
| Other operating expenses | 966 | - |
| Total operating expenses | 17,051 | 16,597 |
| Operating (loss) income | (2,279) | 1,749 |
| Other (expense) income: | ||
| Interest expense | (751) | (974) |
| Loss on equity securities - Note 6 | (1,312) | - |
| Other (expense) income, net | (142) | 432 |
| Total other (expense) income | (2,205) | (542) |
| (Loss) income before income taxes | (4,484) | 1,207 |
| Income tax expense | 210 | 585 |
| Net (loss) income | $(4,694) | $622 |
| (Loss) income per share: | ||
| Basic (loss) income per share | $(0.11) | $0.01 |
| Diluted (loss) income per share | $(0.11) | $0.01 |
| Weighted-average common shares: | ||
| Basic | 43,402 | 42,119 |
| Diluted | 43,402 | 42,783 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.